Stromal Gene Signatures in Large-B-Cell Lymphomas
Georg Lenz(Charité - Universitätsmedizin Berlin), Louis M. Staudt(National Cancer Institute), Gunhild Trøen(Oslo University Hospital), Alastair H. Kyle(University of British Columbia), Armando López‐Guillermo(Barcelona Supercomputing Center), Brad Pohlman(Cleveland Clinic), Lisa M. Rimsza(Banner - University Medical Center Tucson), Wing C. Chan(Ontario Institute for Cancer Research), Joseph M. Connors, Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Elı́as Campo(Hospital Clínic de Barcelona), Randy D. Gascoyne(BC Cancer Agency), Daan Dierickx(KU Leuven), Lorraine F. May(University of British Columbia), John Powell(National Institutes of Health), Timothy C. Greiner(University of Nebraska Medical Center), Wyndham H. Wilson(National Institutes of Health), Javeed Iqbal(University of Nebraska Medical Center), Weihong Xu(World Wide Web Consortium), Elena Hartmann(University of Würzburg), Jamés O. Armitage(University of Nebraska Medical Center), Antonio Martı́nez(Hospital Universitario de Móstoles), James R. Cook(Cleveland Clinic), Emili Montserrat(Universitat de Barcelona), Neta Goldschmidt(National Institutes of Health), John Sweetenham(Cleveland Clinic), Bruce K. Tan(Northwestern University), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Rita M. Braziel(Oregon Health & Science University), Wenming Xiao(World Wide Web Consortium), Jan Delabie, George W. Wright(National Cancer Institute), Sandeep S. Davé(Duke University), Harald Holte(Oslo University Hospital), Elaine S. Jaffe(National Cancer Institute), Hong Zhao(Northwestern University), Kai Fu(Nanjing Medical University), Thomas P. Miller(Queen Elizabeth University Hospital), T. Lister(St Bartholomew's Hospital), DD Weisenburger(TiGenix (Spain)), Müller-Hermelink Hk(University of Würzburg), Julie Vose(Dana-Farber Cancer Institute), Stein Kvaløy(Norwegian Cancer Society), Richard I. Fisher(University of Rochester), Raymond R. Tubbs(Cleveland Clinic), G. Verhoef(TiGenix (Spain)), M. Bast(TiGenix (Spain)), David Wrench(St Bartholomew's Hospital), Erlend B. Smeland(Norwegian Cancer Society), Pedro Jares(Hospital Clínic de Barcelona)
Cited by 1,817
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k